Physician profile
Grace Siqi Liu
NPI 1013379882
$6,839.67
in general payments reported to CMS, 2019-2025
19 companies · $430 in 2025
The $430 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121 · 2021: $1,003 · 2022: $3,914 · 2023: $543 · 2024: $829 · 2025: $430.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,738 · Education: $64.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,738.26 |
| Education | $64.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,071.72 | 2022-2025 | Linq II |
| Boston Scientific Corporation | $1,128.63 | 2021-2024 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $733.94 | 2021-2024 | Lifevest |
| Novo Nordisk INC | $680.37 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Biotronik INC. | $389.38 | 2022-2025 | Acticor 7 Vr-T Dx, Biomonitor, Edora 8 Dr-T |
| Pfizer INC. | $229.26 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $121.84 | 2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $110.04 | 2024-2025 | |
| Kestra Medical Technology Services, INC. | $96.87 | 2024 | Assure Wcd |
| Abbott Laboratories | $64.66 | 2022 | |
| Lilly USA, LLC | $39.98 | 2025 | Zepbound, Mounjaro |
| Impulse Dynamics (USA) INC. | $25.33 | 2023 | Optimizer |
| Amgen INC. | $24.65 | 2023 | Repatha |
| Heartflow, INC. | $23.95 | 2024 | |
| Irhythm Technologies, INC. | $23.11 | 2023 | Zio Xt Patch |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $20.42 | 2025 | |
| Baxter Healthcare | $18.70 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Janssen Biotech, INC. | $18.68 | 2024 | Stelara |
| Astrazeneca Pharmaceuticals Lp | $18.14 | 2025 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.